简体中文
繁體中文
English
Pусский
日本語
ภาษาไทย
Tiếng Việt
Bahasa Indonesia
Español
हिन्दी
Filippiiniläinen
Français
Deutsch
Português
Türkçe
한국어
العربية
Abstract:BENGALURU, June 29 (Reuters) - Procter & Gamble India said it would invest 20 billion rupees ($243.7
BENGALURU, June 29 (Reuters) - Procter & Gamble India said it would invest 20 billion rupees ($243.79 million) to set up a personal healthcare manufacturing facility in the western state of Gujarat.
The company will manufacture digestive products that are part of parent P&Gs global healthcare product portfolio at the facility, it said in a statement on Wednesday.
The facility will be operational in the next few years and become a global export hub for P&G, the Whisper sanitary napkin maker said.
The new facility spans 50,000 square meters in Sanand, Gujarat, and the investment is through an unlisted company and wont affect any listed public companies within the P&G group in India.
($1 = 82.0370 Indian rupees)
Disclaimer:
The views in this article only represent the author's personal views, and do not constitute investment advice on this platform. This platform does not guarantee the accuracy, completeness and timeliness of the information in the article, and will not be liable for any loss caused by the use of or reliance on the information in the article.